Abstract
In this Letter is described the structure-based design of potent dihydro-pyrazoloquinazolines as PDK1 inhibitors. Starting from low potency HTS hits with the aid of X-ray crystallography and modeling, a medicinal chemistry activity was carried out to improve potency versus PDK1 and selectivity versus CDK2 protein kinase.
| Original language | English |
|---|---|
| Pages (from-to) | 4095-4099 |
| Number of pages | 5 |
| Journal | Bioorganic & Medicinal Chemistry Letters |
| Volume | 20 |
| Issue number | 14 |
| Early online date | 8 Jun 2010 |
| DOIs | |
| Publication status | Published - 15 Jul 2010 |
Keywords
- CDK2
- Kinase
- PDK1
- Scaffold
- Structure-based drug design
ASJC Scopus subject areas
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry
- Molecular Medicine
- Molecular Biology
- Clinical Biochemistry
- Biochemistry
Fingerprint
Dive into the research topics of 'Structure-based optimization of potent PDK1 inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver